| ||Nominations and Corporate Governance Committee||Audit Committee||Compensation Committee|
|Armando Anido |
Chairman of the Board and Chief Executive Officer
Armando Anido has served as chairman of our board of directors and as our chief executive officer since
October 2014. Prior to joining our company, Mr. Anido served as our business consultant from May 2014 to
October 2014. Mr. Anido has more than 30 years of executive, operational and commercial leadership
experience in the pharmaceutical industry. Mr. Anido served as chief executive officer and as a director of
NuPathe, Inc., or NuPathe, a publicly-traded specialty pharmaceutical co...
| || || |
|Warren D. Cooper, MB, BS, BSc, MFPM |
|Warren D. Cooper, MB, BS, BSc, MFPM|
Lead Independent Director
Dr. Warren Cooper has served as one of our directors since August 2015 and was appointed lead independent director in November 2015. Dr. Cooper is a UK-trained physician with more than 35 years of experience in the global pharmaceutical industry. Previously, Dr. Cooper was the CEO of Prism Pharmaceuticals, a venture-backed, specialty pharmaceutical company that he led from inception in September 2004 until the sale of the Company to Baxter International in May 2011. His career in the pharmaceuti...
|William J. Federici |
|William J. Federici|
William J. Federici has served as one of our directors since August 2015. Mr. Federici has served as Vice President and Chief Financial Officer of West Pharmaceutical Services, Inc., a publicly traded global pharmaceutical technology company, since August 2003. He served as a member of the Board of Directors at NuPathe Pharmaceuticals, Inc. and Chairman of the Audit committee from January 2011 until February 2014. From June 2002 until August 2003, he was National Industry Director for Pharmaceu...
|Thomas L. Harrison, LH.D |
|Thomas L. Harrison, LH.D|
Dr. Thomas Harrison has served as one of our directors since August 2015. Dr. Harrison is a noted author and speaker and since April 2013, has served as Chairman Emeritus of Diversified Agency Services, the world’s largest group of marketing services companies, and a division of Omnicom Group, Inc. In 1987 he founded Harrison & Star Business Group, a healthcare marketing agency that was acquired by Omnicom in 1992. From 1992-1997, he served as Chairman of the Harrison & Star Group and Chairman o...
|Daniel L. Kisner, M.D. |
|Daniel L. Kisner, M.D.|
Dr. Daniel Kisner has served as one of our directors since August 2015. Dr. Kisner currently serves as a consultant to the pharmaceutical/biotech industry. From 2003-2011 he served as a venture partner/partner at Aberdare Ventures. Prior to that he was President and Chief Executive Officer of Caliper Technologies from 1999 and remained Chairman until 2008. He led Caliper from a startup dealing with microfluidic lab-on-a-chip technology to a publically traded commercial company. From 1991 unt...
| || ||
|Kenneth I. Moch |
|Kenneth I. Moch|
Kenneth I. Moch has served as one of our directors since August 2015. Mr. Moch has more than 25 years of experience in managing and financing biomedical technologies, and has played a key role in building five life science companies. He is currently the president of Euclidean Life Science Advisors LLC, where he provides strategic and tactical counsel to the biotechnology and pharmaceutical industries. Prior to that, he served as president and chief executive officer, and as a director, of Chimer...
|Cynthia A. Rask, M.D. |
|Cynthia A. Rask, M.D.|
Dr. Cynthia A. Rask has served as one of our directors since August 2015. Dr. Rask has more than 20 years of experience working in the pharmaceutical/biotech industry, seven years of FDA experience, and several years of experience as a clinical neurologist and clinical investigator. Dr. Rask trained in Internal Medicine and Neurology at the University of Rochester and is board-certified in Neurology. Following her residency, she did a fellowship in Epilepsy at the Minnesota Comprehensive Epileps...